Clinical trial / 2004
Protocol outlines a randomized trial testing probiotics for predicted severe acute pancreatitis.
This protocol describes a randomized multicenter trial designed to evaluate whether early enteral multispecies probiotics prevent infectious complications in predicted severe acute pancreatitis. A calculated sample of 200 eligible adult patients was planned across 15 Dutch hospitals to receive probiotics or placebo twice daily for 28 days or until discharge. The primary outcome to be evaluated was the total count of infectious complications.
- Study type
- Randomized controlled trial protocol
- Who was studied
- Planned enrollment of 200 adults with predicted severe acute pancreatitis, Netherlands
- What was measured
- Total number of infectious complications
THE PAPER
Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949].
Besselink MG, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG, Dutch Acute Pancreatitis Study Group. BMC Surg, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.